Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema

被引：15
|
作者：
De Simone, L. [1 ]
Sangiovanni, A. [1 ]
Aldigeri, R. [2 ]
Mastrofilippo, V. [1 ,3 ]
Bolletta, E. [1 ]
Invernizzi, A. [4 ,5 ]
Fares, L. [6 ]
Pipitone, N. [7 ]
Fontana, L. [3 ]
Salvarani, C. [7 ,8 ]
Cimino, L. [1 ]
机构：
[1] Azienda USL IRCCS, Ocular Immunol Unit, Reggio Emilia, Italy
[2] Univ Parma, Med & Surg Dept, Parma, Italy
[3] Azienda USL IRCCS, Ophthalmol Dept, Reggio Emilia, Italy
[4] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci Luigi Sacco, Eye Clin, Milan, Italy
[5] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
[6] Azienda USL IRCCS, Pharm Dept, Reggio Emilia, Italy
[7] Azienda USL IRCCS, Div Rheumatol, Reggio Emilia, Italy
[8] Univ Modena & Reggio Emilia, Rheumatol Unit, Modena, Italy
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2020年 / 28卷 / 02期
关键词：
IFN; Interferon alpha-2a; macular edema; post-uveitic; uveitis; LONG-TERM EFFICACY; THERAPY;
D O I：
10.1080/09273948.2019.1589526
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Purpose: To assess the efficacy of interferon (IFN) alpha-2a in the treatment of post-uveitic refractory macular edema (ME). Methods: Retrospective cohort of patients with post-uveitic refractory ME, who received subcutaneous IFN alpha-2a injections for at least 3 months. Baseline central macular thickness (CMT) and best-corrected visual acuity (BCVA) were compared with those at follow-up visits up to 12 months. Results: Thirty-seven patients were included. Treatment duration (median [interquartile range]) was 14[8-24] months with a follow-up of 17[10-38] months. CMT (mean [standard deviation]) decreased from 438[140] to 335[119] mu m after 1 month (p < 0.0001) and remained significantly lower up to 12 months (286[98] mu m, p = 0.001). BCVA (0.48[0.33] logMAR at baseline) improved by 0.26[0.33] logMAR (p = 0.001) at 12 months. There were 14 recurrences. Seven patients had treatment side effects, without serious adverse events. Conclusions: IFN alpha-2a was effective, safe, and well tolerated in treating post-uveitic refractory ME.
引用
收藏
页码：322 / 328
页数：7
相关论文
共 50 条
  • [41] EARLY TREATMENT RESPONSE OF FLUOCINOLONE (RETISERT) IMPLANTATION IN PATIENTS WITH UVEITIC MACULAR EDEMA An Optical Coherence Tomography Study
    Shen, Bailey Y.
    Punjabi, Omar S.
    Lowder, Careen Y.
    Sears, Jonathan E.
    Singh, Rishi P.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (04): : 873 - 877
  • [42] Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behcet's Uveitis: Customizing Therapy according to the Clinical Features
    De Simone, Luca
    Invernizzi, Alessandro
    Aldigeri, Raffaella
    Mastrofilippo, Valentina
    Marvisi, Chiara
    Gozzi, Fabrizio
    Bolletta, Elena
    Adani, Chantal
    Pipitone, Nicolo
    Muratore, Francesco
    Fontana, Luigi
    Salvarani, Carlo
    Cimino, Luca
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (02) : 506 - 514
  • [43] Long-term Efficacy of TNF-alpha Inhibitors on Persistent Uveitic Macular Edema: A Swiss Multicenter Cohort Study
    Bograd, Alexandra
    Fuchs, Dominic
    Baechtiger, Josephin
    Pfister, Isabel B.
    Spindler, Jan
    Hoogewoud, Florence
    Gugleta, Konstantin
    Boeni, Christian
    Guex-Crosier, Yan
    Garweg, Justus G.
    Tappeiner, Christoph
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (05) : 981 - 988
  • [44] Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases
    Bielefeld, Philip
    Devilliers, Herve
    Deschasse, Clemence
    Saadoun, David
    Seve, Pascal
    Muselier, Aurore
    Creuzot-Garcher, Catherine
    Besancenot, Jean-Francois
    Bron, Alain Marie
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (05) : 599 - 602
  • [45] Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema
    Alaa E. Radwan
    Cheryl A. Arcinue
    Paul Yang
    Pichaporn Artornsombudh
    Esam M. Abu Al-Fadl
    C. Stephen Foster
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 1801 - 1806
  • [46] Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema A Multicenter Study from the French Uveitis Network
    Leclercq, Mathilde
    Andrillon, Anais
    Maalouf, Georgina
    Seve, Pascal
    Bielefeld, Philip
    Gueudry, Julie
    Sene, Thomas
    Moulinet, Thomas
    Rouviere, Benedicte
    Sene, Damien
    Desbois, Anne-Claire
    Domont, Fanny
    Touhami, Sara
    El Chamieh, Carolla
    Cacoub, Patrice
    Bodaghi, Bahram
    Biard, Lucie
    Saadoun, David
    OPHTHALMOLOGY, 2022, 129 (05) : 520 - 529
  • [47] Cyclosporin A as an adjunct may enhance the therapeutic effect of interferon alpha-2a in patients with refractory Behcet's uveitis: a retrospective cohort study
    Yang, Peizeng
    Deng, Yang
    Zhang, Yinan
    Zhu, Yunyun
    Huang, Ziqian
    Dai, Lingyu
    Wu, Qiuying
    Su, Guannan
    Cao, Qingfeng
    Lai, Yujie
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2024, 15
  • [48] Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial
    Thorne, Jennifer E.
    Sugar, Elizabeth A.
    Holbrook, Janet T.
    Burke, Alyce E.
    Altaweel, Michael M.
    Vitale, Albert T.
    Acharya, Nisha R.
    Kempen, John H.
    Jabs, Douglas A.
    Jaffe, Glenn J.
    Bunn, Christina F.
    Greene, LaToya
    Grewal, Dilraj
    Grout, Sean
    Hughes, Michael
    Imperio, Ryan
    Kelly, Michael P.
    Lutman, Brian
    Perez, Paola
    Yeh, Steven
    Dobbs, Jannah
    Fernandes, Alcides
    Gibbs, Deborah
    Leef, Donna
    Mazur, Kelly
    O'Keefe, Ghazala
    Waldron, Rhonda
    Thorne, Jennifer E.
    Adeyemo, Olukemi
    Belz, Joseph
    Berkenstock, Meghan
    Boring, Jeff
    Burkholder, Bryn
    Cain, Dennis
    Crowell, Eric
    Distler, Russ
    Emmert, David
    Graul, Janis R.
    Herring, Charles Mark
    Hines, Pat
    Hornbeak, Dana
    Khan, Irfan
    McDonald, Jacquelyn
    Miller, Kelly
    Moore, Robert
    Nwankwo, Antonia
    Okeagu, Chinwenwa
    Reddy, Ashvini
    Reed, Terry L.
    Rhoton, Nicholas
    OPHTHALMOLOGY, 2019, 126 (02) : 283 - 295
  • [49] Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema
    Radwan, Alaa E.
    Arcinue, Cheryl A.
    Yang, Paul
    Artornsombudh, Pichaporn
    Abu Al-Fadl, Esam M.
    Foster, C. Stephen
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (07) : 1801 - 1806
  • [50] Long-Term Outcome of an Intravitreal Dexamethasone Implant for the Treatment of Noninfectious Uveitic Macular Edema
    Habot-Wilner, Zohar
    Sorkin, Nir
    Goldenberg, Dafna
    Loewenstein, Anat
    Goldstein, Michaella
    OPHTHALMOLOGICA, 2014, 232 (02) : 77 - 82
12345